ESC 365 - Predictors of left atrial thrombosis in patients undergoing planned electrical cardioversion of atrial fibrillation treated with direct anticoagulant

ESC Premium Access

Predictors of left atrial thrombosis in patients undergoing planned electrical cardioversion of atrial fibrillation treated with direct anticoagulant

Session: Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Topic: Oral Anticoagulation

Speaker: Doctor V. Lio (Turin, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Veronica Lio

Maria Vittoria Hospital, Turin (Italy)

0 follower

9 more presentations in this session

Autoantiboides to muscarinic m2 cholinoceptors in patients with paroxysmal atrial fibrillation

Speaker: Doctor E. Mironova (Moscow, RU)

Quantitative global proteomics and lysine acetylome analysis of changes in left atrial appendage tissue from valvular heart disease patients with atrial fibrillation

Speaker: Doctor T. Tu (Changsha, CN)

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Speaker: Professor G. Tse (Hong Kong, CN)

CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery

Speaker: Doctor N. Kazem (Vienna, AT)

Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

Speaker: Doctor P. Buettner (Leipzig, DE)

Access the full session

Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Speakers: Doctor V. Lio, Doctor E. Mironova, Doctor T. Tu, Professor G. Tse, Doctor N. Kazem...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources